News
Facing patent expiration for its blockbuster Keytruda, Merck aims to streamline operations with significant job cuts and ...
GSK signed a 12-asset licensing deal with Hengrui Pharma. Generic erosion on Vyvanse continued to hurt Takeda. Celltrion is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback